Skip to content

LABO PLUS

Active
Private limited companyfounded 201016 yrs activeRoodebeeksteenweg 101, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 0822.666.896

LABO PLUS has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €137k and a net result of €-6k. Equity is growing by ~6.5% per year across the filed fiscal years. Its solvency ranks better than 41% of 15867 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2024
55 / 100
Fair▼ -24 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0▼-32
Solvency48=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity tight (current ratio 1.3 against 1.27 in 2023), and 72.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
27.2%
Return on assets
-1.1%
Age of the figures
20 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-09-2025, 47 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
47 d late
2023
54 d late
2022
60 d late
2021
52 d late
2020
100 d late
2019
70 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€137k▼ 4.0%
2023 · €142k
2018: €52k 2019: €111k 2020: €118k 2021: €137k 2022: €133k 2023: €142k
2018 → 2024
Total assets
€502k▼ 4.8%
2023 · €527k
2018: €201k 2019: €259k 2020: €316k 2021: €457k 2022: €415k 2023: €527k
2018 → 2024
Net result
€-6k
2023 · €9k
2018: €36k 2019: €58k 2020: €8k 2021: €19k 2022: €-4k 2023: €9k
2018 → 2024
Working capital
€110k▲ 4.2%
2023 · €106k
2018: €45k 2019: €97k 2020: €84k 2021: €106k 2022: €84k 2023: €106k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€118k-€137k▲ 15.9%€133k▼ 2.7%€142k▲ 6.8%€137k▼ 4.0%
Operating result€13k-€32k▲ 147%€5k▼ 83.2%€20k▲ 270%€-5k
Net result€8k-€19k▲ 148%€-4k€9k€-6k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-10k€0€10k€20k€30kOperating result 2020: €13k€13kNet result 2020: €8k€8kOperating result 2021: €32k€32kNet result 2021: €19k€19kOperating result 2022: €5k€5kNet result 2022: €-4k€-4kOperating result 2023: €20k€20kNet result 2023: €9k€9kOperating result 2024: €-5k€-5kNet result 2024: €-6k€-6k20202021202220232024
The operating result turns negative in 2024: a loss of €5k after €20k in 2023, the lowest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €502k
Fixed assets €26k▼ 27.8%
Current assets €476k▼ 3.1%
Equity and liabilities €502k
Equity €137k▼ 4.0%
Debt €366k▼ 5.1%
The debt ratio falls from 73.0% to 72.8%: debt falls faster than equity shrinks.
Key figures and ratios
2024 value · change against 2023
EBITDA
€5k
2023 · €33k
Cash flow
€4k
2023 · €22k
Solvency
27.2%
2023 · 27.0%
Current ratio
1.30
2023 · 1.27
Quick ratio
1.30
2023 · 1.27
Debt / equity
2.68
2023 · 2.71
ROE
-4.1%
2023 · 6.4%
ROA
-1.1%
2023 · 1.7%
Interest coverage
13.30
2023 · 122.25
Debt
€366k
2023 · €385k
Debt ≤ 1 year
€366k
2023 · €385k
Staff costs
€229k
2023 · €228k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€527k€502k
Fixed assets21/28€36k€26k
Tangible fixed assets22/27€34k€24k
Furniture and vehicles24€5k€2k
Other tangible fixed assets26€29k€22k
Financial fixed assets28€2k€2k=
Current assets29/58€491k€476k
Amounts receivable within one year40/41€466k€470k
Trade receivables40€466k€469k
Other amounts receivable41€709€709=
Cash at bank and in hand54/58€24k€6k
Deferred charges and accrued income490/1-€429
Equity and liabilities
Total equity and liabilities10/49€527k€502k
Equity10/15€142k€137k
Contributions10/11€20k€20k=
Outside capital11€20k€20k=
Other1109/19€20k€20k=
Profit (loss) carried forward14€122k€116k
Amounts payable17/49€385k€366k
Amounts payable within one year42/48€385k€366k
Current portion of amounts payable after more than one year42€794-
Trade debts44€332k€303k
Suppliers440/4€332k€303k
Taxes, remuneration and social security45€49k€59k
Taxes450/3€14k€18k
Remuneration and social security454/9€35k€42k
Other amounts payable47/48€3k€3k=
Income statement Code20232024
Remuneration, social security and pensions62€228k€229k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€10k
Other operating charges640/8€870€356
Gross operating margin9900€262k€235k
Operating profit (loss)9901€20k€-5k
Financial income75/76B€9-
Recurring financial income75€9-
Financial charges65/66B€267€363
Recurring financial charges65€267€363
Profit (loss) for the period before taxes9903€20k€-6k
Income taxes67/77€11k-
Profit (loss) for the period9904€9k€-6k
Profit (loss) for the period to be appropriated9905€9k€-6k
Appropriation of the result
Profit (loss) to be appropriated9906€122k€116k
Profit (loss) brought forward from the previous period14P€113k€122k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
19-08
State Gazette act Resignations & appointments
General meeting · Director appointment2 facts ▸
  • General meeting, 2026-08-08
  • Director appointment, Selin Erdil (administratrice supplémentaire)
2025
16-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 47 days late
2024
31-12
Financial Weakest financial yearnet €-6k ▼162%
Net result drops to €-6k, the lowest in the series.
23-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 54 days late
2023
31-12
Financial Back to profitnet €9k
Net result €9k after one loss-making year.
29-09
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
21-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 52 days late
2021
08-11
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 100 days late
2020
09-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 70 days late
2019
31-12
Financial Highest result since 2018net €58k ▲60.4%
Operating result €88k, net result €58k, both a record.
31-12
Financial Equity above €100kEq €111k ▲112%
2 profitable years in a row build equity to €111k.
26-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 31 days late
2017
02-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 2 days late
2016
18-08
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 18 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 directors, no change since 2026
Selin Erdil
Administratrice supplémentaire · since 10-08-2026
Current
10-08-2026 Selin Erdil: Appointed as Administratrice supplémentaire
03-07-2025 KANLIBAS Deniz: Resigned as Director
30-04-2020 Romain LINET: Resigned as Managing director
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2010
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Roodebeeksteenweg 1011200 Sint-Lambrechts-Woluwe
Ground area
475 m²
Building footprint
447 m²
Volume, LiDAR
5,298 m³
2 parcels, Brussels · tallest building 19.0 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
LABO PLUS
Oudergemlaan 149, 1040 EtterbeekManufacture of medical and dental instruments and supplies
since 20102.231.657.521
2 parcels
Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21672C0052/00B004 Brussels 369 m² 1 · 368 m² 19.0 m · 4 fl.
21364B0005/00W006 Brussels 106 m² 1 · 79 m² 17.7 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,245 companies in sector 32500 we hold annual accounts for 692. 547 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded27-01-2010
Fiscal year end31-12
Abbreviation FR LABO+
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
46190Agents in non-specialised wholesale trade
46460Wholesale of pharmaceutical and medical goods
68110Buying and selling of own real estate
70210Activities of head offices; management consultancy activities
73110Advertising agencies
73300Public relations and communication consultancy
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.